News: ANZUP
ENZAMET shows promise as prostate cancer treatment
The results from the clinical trial of ENZAMET, co-chaired by Professor Christopher Sweeney, Director of the South Australian immunoGENomics Cancer Institute (SAiGENCI) that operates within the University of Adelaide, have been published today in .
[Read more about ENZAMET shows promise as prostate cancer treatment ]
![RSS News Feed](/global/images/rss.gif" "RSS News Feed"){kind=small}